Dan Ye

3.7k total citations
124 papers, 2.8k citations indexed

About

Dan Ye is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Dan Ye has authored 124 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 33 papers in Cardiology and Cardiovascular Medicine and 21 papers in Oncology. Recurrent topics in Dan Ye's work include Cardiac electrophysiology and arrhythmias (31 papers), Ion channel regulation and function (25 papers) and Cholesterol and Lipid Metabolism (10 papers). Dan Ye is often cited by papers focused on Cardiac electrophysiology and arrhythmias (31 papers), Ion channel regulation and function (25 papers) and Cholesterol and Lipid Metabolism (10 papers). Dan Ye collaborates with scholars based in China, United States and Netherlands. Dan Ye's co-authors include Steven R. Blanke, Michael J. Ackerman, David J. Tester, Theo J.C. van Berkel, Miranda Van Eck, David C. Willhite, Bing‐Liang Ma, George Kemble, Reeni B. Hildebrand and Hong Jin and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Dan Ye

116 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Ye China 31 1.1k 604 587 406 390 124 2.8k
Chris Van Geet Belgium 34 926 0.8× 272 0.5× 291 0.5× 255 0.6× 266 0.7× 145 3.6k
Keiko Suzuki Japan 25 808 0.7× 234 0.4× 332 0.6× 301 0.7× 295 0.8× 191 2.7k
Satoshi Fujii Japan 35 1.9k 1.7× 417 0.7× 624 1.1× 673 1.7× 604 1.5× 149 4.5k
Azeddine Ibrahimi Morocco 27 2.0k 1.8× 358 0.6× 350 0.6× 162 0.4× 395 1.0× 130 3.6k
Nazima Pathan United Kingdom 25 1.3k 1.2× 347 0.6× 222 0.4× 459 1.1× 591 1.5× 79 3.0k
Jean-Paul Chapelle Belgium 25 783 0.7× 202 0.3× 283 0.5× 282 0.7× 305 0.8× 88 2.4k
Jianhua Lu China 33 981 0.9× 392 0.6× 135 0.2× 230 0.6× 688 1.8× 117 2.9k
R L Simmons United States 32 832 0.8× 831 1.4× 366 0.6× 1.1k 2.6× 583 1.5× 62 4.6k
Tomohiro Nakayama Japan 30 958 0.9× 430 0.7× 880 1.5× 214 0.5× 488 1.3× 223 3.6k
Juan Wang China 34 2.1k 2.0× 249 0.4× 172 0.3× 749 1.8× 471 1.2× 186 4.2k

Countries citing papers authored by Dan Ye

Since Specialization
Citations

This map shows the geographic impact of Dan Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Ye more than expected).

Fields of papers citing papers by Dan Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Ye. The network helps show where Dan Ye may publish in the future.

Co-authorship network of co-authors of Dan Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Ye. A scholar is included among the top collaborators of Dan Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Ye. Dan Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cheng, C. C., Li Duan, Qian Fu, et al.. (2025). Determination of tylosin A, tylvalosin, and tilmicosin in feed using a novel magnetic mixed cation exchange material (M-MCX). Microchemical Journal. 215. 114472–114472. 1 indexed citations
3.
Li, Ziqi, et al.. (2024). TAK-3 Inhibits Lipopolysaccharide-Induced Neuroinflammation in Traumatic Brain Injury Rats Through the TLR-4/NF-κB Pathway. Journal of Inflammation Research. Volume 17. 2147–2158. 4 indexed citations
4.
Ye, Dan, Xiaozhi Gao, David J. Tester, et al.. (2024). Clinical Utility of Protein Language Models in Resolution of Variants of Uncertain Significance in KCNQ1, KCNH2 , and SCN5A Compared With Patch-Clamp Functional Characterization. Circulation Genomic and Precision Medicine. 17(5). e004584–e004584.
5.
Sun, Ying, Yongxiang Zhang, Tingting Yan, et al.. (2023). The preparation of high minoxidil loaded transfersomes and its gel for effective topical treatment of alopecia. Journal of Drug Delivery Science and Technology. 84. 104458–104458. 14 indexed citations
6.
Wang, Zhao, Hongmei Zhou, Delu Che, et al.. (2023). Activation of ryanodine-sensitive calcium store drives pseudo-allergic dermatitis via Mas-related G protein-coupled receptor X2 in mast cells. Frontiers in Immunology. 14. 1207249–1207249. 1 indexed citations
8.
Zhou, Wei, Dan Ye, David J. Tester, et al.. (2023). Elucidation of ALG10B as a Novel Long-QT Syndrome–Susceptibility Gene. Circulation Genomic and Precision Medicine. 16(2). 4 indexed citations
10.
Hanker, Ariella B., Benjamin P. Brown, Jens Meiler, et al.. (2021). Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity. Cancer Cell. 39(8). 1099–1114.e8. 53 indexed citations
11.
Giudicessi, John R., Dan Ye, Hennie Bikker, et al.. (2021). A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome. Heart Rhythm. 19(3). 435–442. 10 indexed citations
12.
Gao, Xiaozhi, Dan Ye, Wei Zhou, et al.. (2021). A novel functional variant residing outside the SCN5A-encoded Nav1.5 voltage-sensing domain causes multifocal ectopic Purkinje-related premature contractions. HeartRhythm Case Reports. 8(1). 54–59. 7 indexed citations
13.
Lei, Hui, Feng Ye, Xiaoqing Liu, et al.. (2020). SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients. Influenza and Other Respiratory Viruses. 14(6). 688–699. 60 indexed citations
14.
Ye, Dan, Wei Zhou, David J. Tester, et al.. (2019). Abstract 12335: Acacetin, a Potent Transient Outward Current Blocker, May Serve as a Novel Therapeutic for KCND3-encoded Kv4.3 Gain-of-function-associated Brugada Syndrome. Circulation. 1 indexed citations
17.
Zhao, Chenyan, et al.. (2017). Comparison of different cold therapy programs on delayed-onset muscle soreness. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 21(24). 3827. 1 indexed citations
18.
Giudicessi, John R., Dan Ye, Vladislav V. Nesterenko, et al.. (2012). Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Human Mutation. 33(6). 989–997. 60 indexed citations
19.
Yang, Chin‐Fen, Robert B. Belshe, George Kemble, et al.. (2010). Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine. Vaccine. 28(31). 5128–5134. 5 indexed citations
20.
Ye, Dan, Illiana Meurs, Laura Calpe‐Berdiel, et al.. (2010). Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice. Biochemical and Biophysical Research Communications. 395(3). 387–394. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026